[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363097-105":59,"doc-detail-363097-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-cholesterol-driven-immunometabolism-in-cancer-review","Targeting cholesterol-driven immunometabolism in cancer - review","","Cholesterol integrates membrane organization, oncogenic signaling, and tumor immune regulation, and cancer commonly rewires cholesterol homeostasis, linking dysregulated cholesterol metabolism to tumor initiation and progression. Evidence shows a mutually reinforcing interplay in which oncogenic pathways boost cholesterol biosynthesis, supporting growth, metastasis, and immune evasion. Cholesterol also signals through membrane microdomains and stress-adaptation pathways, while within the tumor microenvironment it remodels sterol flux and oxysterol signaling, affecting antigen presentation, T-cell fate, and myeloid polarization. Clinical translation remains limited by poor tumor specificity, metabolic plasticity, and context-dependent tumor–immune interactions; next-generation approaches require optimization, biomarkers, and patient stratification aligned with precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-cholesterol-driven-immunometabolism-in-cancer-review/363097/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-cholesterol-driven-immunometabolism-in-cancer-review/363097.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does cholesterol metabolism contribute to cancer initiation and progression?","Question",{"text":112,"@type":113},"Cancer frequently rewires cholesterol homeostasis, and dysregulated cholesterol metabolism is increasingly recognized as a key contributor to tumor initiation and progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the relationship between oncogenic pathways and cholesterol metabolism?",{"text":117,"@type":113},"Oncogenic pathways and cholesterol metabolism reinforce each other: malignant transformation upregulates cholesterol biosynthesis and related programs, and the resulting metabolic reprogramming supports tumor growth, metastatic competence, and immune evasion.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is clinical translation of cholesterol-modulating therapies still limited?",{"text":121,"@type":113},"Clinical translation is limited by poor tumor specificity of existing drugs, cancer cell metabolic plasticity, and context-dependent interactions between tumor cells and the immune system.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363097,1790624714,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Ma etal. Molecular Cancer (2026) 25:115 Molecular Cancer  \n[https://doi.org/10.1186/s12943-026-02631-8](https://doi.org/10.1186/s12943-026-02631-8)  \nREVIEW Open Access  \nTargeting cholesterol-driven immunometabolism in cancer: from molecular circuits to clinical translation  \nQiang Ma1, Bonan Chen2,3,4, Tingting Li5, Yanhui Lu6* and Xiaoguang Li 1*  \nAbstract  \nCholesterol integrates membrane organization, oncogenic signaling, and tumor immune regulation. Consistent with this central role, cholesterol homeostasis is frequently rewired in cancer, and dysregulated cholesterol metabolism is increasingly recognized as a key contributor to tumor initiation and progression. Accumulating evidence indicates a mutually reinforcing interplay between oncogenic pathways and cholesterol metabolism:  \nmalignant transformation upregulates cholesterol biosynthesis and related homeostatic programs, and the ensuing metabolic reprogramming supports tumor growth, metastatic competence, and immune evasion. Beyond serving as structural components of cellular membranes in proliferating cells, cholesterol and its derivatives can act as signaling mediators that reshape membrane microdomains, reprogram oncogenic circuitry, and modulate stressadaptation pathways in a context-dependent manner. Importantly, cholesterol metabolism is also remodeled in immune cells within the tumor microenvironment, where alterations in sterol flux and oxysterol signaling can influence antigen presentation, T-cell activation versus dysfunction, and myeloid polarization, thereby shaping responses to immunotherapy. Although cholesterol metabolism represents a promising therapeutic target, clinical translation of cholesterol-modulating agents remains limited. Key obstacles include the poor tumor specificity of current drugs (e. g., statins and cholesterol absorption inhibitors), cancer cell metabolic plasticity, and contextdependent tumor-immune interactions. Emerging next-generation strategies encompass enzymatic inhibitors, targeted delivery platforms, and gene-editing systems. While these approaches show promising preclinical results, their clinical translation demands systematic optimization, pharmacodynamic biomarker development, and patient stratification aligned with precision oncology principles. This review synthesizes mechanistic links between cholesterol-driven metabolic rewiring and cancer and critically appraises preclinical and clinical advances, including representative clinical trials combining cholesterol-lowering interventions with systemic anti-cancer therapies. Keywords Cholesterol metabolism, Immunometabolism, Tumor microenvironment, Precision oncology  \n*Correspondence: Yanhui Lu[luyanhui@bjmu.edu.cn](luyanhui@bjmu.edu.cn)[ ](luyanhui@bjmu.edu.cn)Xiaoguang Li[lixg@shsmu.edu.cn](lixg@shsmu.edu.cn)  \n1State Key Laboratory of Systems Medicine for Cancer, Center for SingleCell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China  \n2Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y. K. Pao Cancer Center, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China 3Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China  \n4CUHK-Shenzhen Research Institute, Shenzhen, China  \n5Shanghai University of Medicine & Health Sciences, Shanghai, China 6School of Nursing, Peking University, Beijing 100191, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. ","cbCaimv9ax1wYm5T","https://ap.wps.com/l/cbCaimv9ax1wYm5T","pdf",1958843,16,"English","# Abstract\n# Introduction","[{\"question\":\"How does cholesterol metabolism contribute to cancer initiation and progression?\",\"answer\":\"Cancer frequently rewires cholesterol homeostasis, and dysregulated cholesterol metabolism is increasingly recognized as a key contributor to tumor initiation and progression.\"},{\"question\":\"What is the relationship between oncogenic pathways and cholesterol metabolism?\",\"answer\":\"Oncogenic pathways and cholesterol metabolism reinforce each other: malignant transformation upregulates cholesterol biosynthesis and related programs, and the resulting metabolic reprogramming supports tumor growth, metastatic competence, and immune evasion.\"},{\"question\":\"Why is clinical translation of cholesterol-modulating therapies still limited?\",\"answer\":\"Clinical translation is limited by poor tumor specificity of existing drugs, cancer cell metabolic plasticity, and context-dependent interactions between tumor cells and the immune system.\"}]","Targeting cholesterol-driven immunometabolism in cancer - review | PDF",1790150011,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f12463e5dafa0d3ce6a8328fe6783e5e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fc8a1e11cccf2e7fccb7c417c69f70e.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8e0b17775321e224755e37f3c104b94.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ef988e975eed01a1e455629ffffe733.webp",980,1306]